Bio-Reference Laboratories (BRLI) 27.62 $BRLI
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2014
GlobeNewswire - Thu Dec 11, 7:56AM CST
BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the fourth quarter and year end for 2014 before the open of market trading on Thursday, December 18, 2014. The Company's earnings conference call is to take place the same day at 10:30 a.m. EST. The call will be hosted by Marc D. Grodman M.D., President and Chief Executive Officer.
BRLI: 27.62 (+0.14)
Bio-Reference Laboratories Tested: Undisclosed Lawsuit Alleges Fraud, Ex-Employees Speak Out
The GeoTeam - Seeking Alpha - Wed Dec 10, 9:15AM CST
By now, some of the extremely obvious risks to investing in Bio-Reference Laboratories (NASDAQ: BRLI ) have been in the public domain for a while. Questions have been raised about ties to organized crime, stuffing envelopes full of cash for...
BRLI: 27.62 (+0.14), DGX: 63.42 (-1.40), LH: 101.92 (-2.08)
Bear of the Day: Invacare Corp (IVC) - Bear of the Day
Brian Hamilton - ZACKS - Mon Nov 24, 12:00AM CST
Bear of the Day: Invacare Corp (IVC) - Bear of the Day
BRLI: 27.62 (+0.14), IVC: 16.50 (-0.43), STE: 65.55 (-0.75), MMSI: 16.41 (+0.02)
CR Bard (BCR) Scales 52-Week High on Strong Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 12:10PM CST
Impressive third-quarter 2014 results reflecting double-digit bottom-line growth, the recent FDA approval for its Lutonix DCB along with a robust product pipeline contribute to the growth trajectory of this company.
ABC: 90.98 (-1.57), BCR: 167.49 (-1.66), BRLI: 27.62 (+0.14), STE: 65.55 (-0.75)
DENTSPLY (XRAY) Hits New 52-Week High on Q3 Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 10:40AM CST
DENTSPLY International Inc. (XRAY) continues to execute on its overall growth strategy via margin expansion, better asset utilization and product innovation.
ABC: 90.98 (-1.57), BRLI: 27.62 (+0.14), STE: 65.55 (-0.75), XRAY: 54.21 (-0.24)
MWI Veterinary Beats Q4 Earnings & Sales yet Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 9:00AM CST
MWI Veterinary's (MWIV) share price has declined 8.7% since the announcement of the fourth quarter results to close at $155.00 yesterday.
ABC: 90.98 (-1.57), BCR: 167.49 (-1.66), BRLI: 27.62 (+0.14), MWIV: 165.54 (+0.44)
Henry Schein Tops Q3 Earnings, Revenues; Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:30AM CST
Henry Schein's (HSIC) share price jumped 6.1% to eventually close at $129.62 yesterday.
ABC: 90.98 (-1.57), BCR: 167.49 (-1.66), BRLI: 27.62 (+0.14), HSIC: 133.80 (-1.20)
Steris Gains on Q2 Earnings and Revenue Beat; EPS View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 9:10AM CST
Following the earnings release, Steris' (STE) share price rose 1.9% to eventually close at $63.64 yesterday.
ABC: 90.98 (-1.57), BCR: 167.49 (-1.66), BRLI: 27.62 (+0.14), STE: 65.55 (-0.75)
DENTSPLY (XRAY) Beats Q3 Earnings, Misses on Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 3:30PM CDT
DENTSPLY International Inc. (XRAY) reported third-quarter 2014 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate by a couple of cents.
BRLI: 27.62 (+0.14), STE: 65.55 (-0.75), HSIC: 133.80 (-1.20), XRAY: 54.21 (-0.24)
Nasdaq stocks posting largest percentage decreases
AP - Fri Aug 29, 12:19PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
PSBH: 7.67 (+0.42), TRVN: 4.01 (-0.23), KNDI: 12.45 (-0.40), SWIR: 40.14 (-0.03), BRLI: 27.62 (+0.14), FRED: 15.82 (+0.87), SNSS: 2.26 (unch), SW.TO: 46.43 (+0.15), INFI: 17.78 (-0.21), ORPN: 6.71 (-0.54)
Bio-Reference Laboratories (BRLI) Crumbles: Stock Tumbles by 9.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 7:30AM CDT
Bio-Reference Laboratories has been witnessing flat earnings estimate revision and its share price has been falling for past 24 hours
ICUI: 80.95 (-1.04), BRLI: 27.62 (+0.14), ABAX: 57.20 (+0.61), CNAT: 7.94 (+0.20)
Williams-Sonoma Stumbles After Yesterday's Surge
at The Street - Thu Aug 28, 12:11PM CDT
Repros Therapeutics Inc (NASDAQ:RPRX), Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) and Signet Jewelers Ltd. (NYSE:SIG) are today's top-gaining billionaire stock picks midday. The losers are Williams-...
BRLI: 27.62 (+0.14), AQXP: 7.40 (-0.10), RPRX: 8.74 (+0.26), VMEM: 4.53 (-0.18), SIG: 126.95 (-0.30)
BioReference Laboratories, Inc. Reports Record Quarterly Revenues and Patient Volumes for Third Quarter FY2014
GlobeNewswire - Wed Aug 27, 7:30AM CDT
BioReference Laboratories, Inc. (Nasdaq:BRLI) announces record third quarter results for revenues and patient volumes. Except for per share data or where otherwise noted, numbers are in thousands.
BRLI: 27.62 (+0.14)
5 Hated Earnings Stocks You Should Love
at The Street - Mon Aug 25, 12:04PM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
BRLI: 27.62 (+0.14), ARUN: 19.49 (-0.03), WDAY: 81.58 (-1.40), TSL: 8.82 (-0.30), NMBL: 27.53 (+0.06)
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2014
GlobeNewswire - Wed Aug 20, 8:29AM CDT
BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the third quarter 2014 before the open of market trading on Wednesday, August 27, 2014. The Company's earnings conference call is to take place the same day at 10:30 a.m. EDT. The call will be hosted by Marc D. Grodman M.D., President and Chief Executive Officer.
BRLI: 27.62 (+0.14)
Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc.
PR Newswire - Mon Aug 18, 4:24PM CDT
Sterne, Kessler, Goldstein & Fox P.L.L.C., an intellectual property law firm in Washington, DC, announced today that it has filed eleven petitions for Inter Partes Review (IPR) with the U.S. Patent and Trademark Office (USPTO) on behalf of GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc. (Nasdaq: BRLI). These IPR petitions aim to nullify eleven patents owned, co-owned, or licensed by Myriad Genetics, Inc. These patents have been asserted against GeneDx in patent infringement litigation initiated in the United States District Court for the District of Utah on October 17, 2013.
BRLI: 27.62 (+0.14)
Myriad Genetics Guidance Disappoints, Q4 Edges Views
at Investor's Business Daily - Tue Aug 12, 6:16PM CDT
Gene-tester Myriad Genetics modestly beat fiscal Q4 estimates late Tuesday, but EPS guidance below consensus sent the stock falling 5% in after-hours trading. Revenue for the quarter that ended June 30 rose 8.4% over the year-earlier quarter to...
MYGN: 33.98 (-1.15), BRLI: 27.62 (+0.14), DGX: 63.42 (-1.40)
Myriad Genetics' Earnings Face 'Angelina Jolie' Comps
at Investor's Business Daily - Mon Aug 11, 11:43AM CDT
Gene-testing company Myriad Genetics (MYGN) will report fiscal Q4 earnings after the close Tuesday that Wall Street expects will show tougher year-over-year comparisons for the high-rated stock. Analysts' consensus calls for 8% sales growth to $187.7...
MYGN: 33.98 (-1.15), BRLI: 27.62 (+0.14), DGX: 63.42 (-1.40)
BioReference Laboratories, Inc. Announces Earnings Date for Fourth Quarter and Year End for Fiscal Year 2014
GlobeNewswire - Thu Dec 11, 7:56AM CST
BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the fourth quarter and year end for 2014 before the open of market trading on Thursday, December 18, 2014. The Company's earnings conference call is to take place the same day at 10:30 a.m. EST. The call will be hosted by Marc D. Grodman M.D., President and Chief Executive Officer.
BRLI: 27.62 (+0.14)
Bio-Reference Laboratories Tested: Undisclosed Lawsuit Alleges Fraud, Ex-Employees Speak Out
The GeoTeam - Seeking Alpha - Wed Dec 10, 9:15AM CST
By now, some of the extremely obvious risks to investing in Bio-Reference Laboratories (NASDAQ: BRLI ) have been in the public domain for a while. Questions have been raised about ties to organized crime, stuffing envelopes full of cash for...
BRLI: 27.62 (+0.14), DGX: 63.42 (-1.40), LH: 101.92 (-2.08)
Bear of the Day: Invacare Corp (IVC) - Bear of the Day
Brian Hamilton - ZACKS - Mon Nov 24, 12:00AM CST
Bear of the Day: Invacare Corp (IVC) - Bear of the Day
BRLI: 27.62 (+0.14), IVC: 16.50 (-0.43), STE: 65.55 (-0.75), MMSI: 16.41 (+0.02)
CR Bard (BCR) Scales 52-Week High on Strong Q3 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 12:10PM CST
Impressive third-quarter 2014 results reflecting double-digit bottom-line growth, the recent FDA approval for its Lutonix DCB along with a robust product pipeline contribute to the growth trajectory of this company.
ABC: 90.98 (-1.57), BCR: 167.49 (-1.66), BRLI: 27.62 (+0.14), STE: 65.55 (-0.75)
DENTSPLY (XRAY) Hits New 52-Week High on Q3 Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 10:40AM CST
DENTSPLY International Inc. (XRAY) continues to execute on its overall growth strategy via margin expansion, better asset utilization and product innovation.
ABC: 90.98 (-1.57), BRLI: 27.62 (+0.14), STE: 65.55 (-0.75), XRAY: 54.21 (-0.24)
MWI Veterinary Beats Q4 Earnings & Sales yet Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 9:00AM CST
MWI Veterinary's (MWIV) share price has declined 8.7% since the announcement of the fourth quarter results to close at $155.00 yesterday.
ABC: 90.98 (-1.57), BCR: 167.49 (-1.66), BRLI: 27.62 (+0.14), MWIV: 165.54 (+0.44)
Henry Schein Tops Q3 Earnings, Revenues; Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:30AM CST
Henry Schein's (HSIC) share price jumped 6.1% to eventually close at $129.62 yesterday.
ABC: 90.98 (-1.57), BCR: 167.49 (-1.66), BRLI: 27.62 (+0.14), HSIC: 133.80 (-1.20)
Steris Gains on Q2 Earnings and Revenue Beat; EPS View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 9:10AM CST
Following the earnings release, Steris' (STE) share price rose 1.9% to eventually close at $63.64 yesterday.
ABC: 90.98 (-1.57), BCR: 167.49 (-1.66), BRLI: 27.62 (+0.14), STE: 65.55 (-0.75)
DENTSPLY (XRAY) Beats Q3 Earnings, Misses on Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 3:30PM CDT
DENTSPLY International Inc. (XRAY) reported third-quarter 2014 adjusted earnings of 62 cents per share, which beat the Zacks Consensus Estimate by a couple of cents.
BRLI: 27.62 (+0.14), STE: 65.55 (-0.75), HSIC: 133.80 (-1.20), XRAY: 54.21 (-0.24)
Nasdaq stocks posting largest percentage decreases
AP - Fri Aug 29, 12:19PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
PSBH: 7.67 (+0.42), TRVN: 4.01 (-0.23), KNDI: 12.45 (-0.40), SWIR: 40.14 (-0.03), BRLI: 27.62 (+0.14), FRED: 15.82 (+0.87), SNSS: 2.26 (unch), SW.TO: 46.43 (+0.15), INFI: 17.78 (-0.21), ORPN: 6.71 (-0.54)
Bio-Reference Laboratories (BRLI) Crumbles: Stock Tumbles by 9.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 7:30AM CDT
Bio-Reference Laboratories has been witnessing flat earnings estimate revision and its share price has been falling for past 24 hours
ICUI: 80.95 (-1.04), BRLI: 27.62 (+0.14), ABAX: 57.20 (+0.61), CNAT: 7.94 (+0.20)
Williams-Sonoma Stumbles After Yesterday's Surge
at The Street - Thu Aug 28, 12:11PM CDT
Repros Therapeutics Inc (NASDAQ:RPRX), Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) and Signet Jewelers Ltd. (NYSE:SIG) are today's top-gaining billionaire stock picks midday. The losers are Williams-...
BRLI: 27.62 (+0.14), AQXP: 7.40 (-0.10), RPRX: 8.74 (+0.26), VMEM: 4.53 (-0.18), SIG: 126.95 (-0.30)
BioReference Laboratories, Inc. Reports Record Quarterly Revenues and Patient Volumes for Third Quarter FY2014
GlobeNewswire - Wed Aug 27, 7:30AM CDT
BioReference Laboratories, Inc. (Nasdaq:BRLI) announces record third quarter results for revenues and patient volumes. Except for per share data or where otherwise noted, numbers are in thousands.
BRLI: 27.62 (+0.14)
5 Hated Earnings Stocks You Should Love
at The Street - Mon Aug 25, 12:04PM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
BRLI: 27.62 (+0.14), ARUN: 19.49 (-0.03), WDAY: 81.58 (-1.40), TSL: 8.82 (-0.30), NMBL: 27.53 (+0.06)
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter Fiscal Year 2014
GlobeNewswire - Wed Aug 20, 8:29AM CDT
BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today it plans to issue earnings results for the third quarter 2014 before the open of market trading on Wednesday, August 27, 2014. The Company's earnings conference call is to take place the same day at 10:30 a.m. EDT. The call will be hosted by Marc D. Grodman M.D., President and Chief Executive Officer.
BRLI: 27.62 (+0.14)
Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc.
PR Newswire - Mon Aug 18, 4:24PM CDT
Sterne, Kessler, Goldstein & Fox P.L.L.C., an intellectual property law firm in Washington, DC, announced today that it has filed eleven petitions for Inter Partes Review (IPR) with the U.S. Patent and Trademark Office (USPTO) on behalf of GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc. (Nasdaq: BRLI). These IPR petitions aim to nullify eleven patents owned, co-owned, or licensed by Myriad Genetics, Inc. These patents have been asserted against GeneDx in patent infringement litigation initiated in the United States District Court for the District of Utah on October 17, 2013.
BRLI: 27.62 (+0.14)
Myriad Genetics Guidance Disappoints, Q4 Edges Views
at Investor's Business Daily - Tue Aug 12, 6:16PM CDT
Gene-tester Myriad Genetics modestly beat fiscal Q4 estimates late Tuesday, but EPS guidance below consensus sent the stock falling 5% in after-hours trading. Revenue for the quarter that ended June 30 rose 8.4% over the year-earlier quarter to...
MYGN: 33.98 (-1.15), BRLI: 27.62 (+0.14), DGX: 63.42 (-1.40)
Myriad Genetics' Earnings Face 'Angelina Jolie' Comps
at Investor's Business Daily - Mon Aug 11, 11:43AM CDT
Gene-testing company Myriad Genetics (MYGN) will report fiscal Q4 earnings after the close Tuesday that Wall Street expects will show tougher year-over-year comparisons for the high-rated stock. Analysts' consensus calls for 8% sales growth to $187.7...
MYGN: 33.98 (-1.15), BRLI: 27.62 (+0.14), DGX: 63.42 (-1.40)
